ALLOGENE THERAPEUTICS

Serial Number 88136814
Registration 5933529
700

Registration Progress

Application Filed
Sep 28, 2018
Under Examination
Apr 23, 2019
Approved for Publication
Feb 26, 2019
Published for Opposition
Feb 26, 2019
Registered
Dec 10, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-10)
Due: Dec 10, 2025 127 days

Trademark Image

ALLOGENE THERAPEUTICS

Basic Information

Serial Number
88136814
Registration Number
5933529
Filing Date
September 28, 2018
Registration Date
December 10, 2019
Published for Opposition
February 26, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2019
Registration
Registered
Classes
005

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Colleen Ganin

USPTO Deadlines

Next Deadline
127 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-10)
Due Date
December 10, 2025
Grace Period Ends
June 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Feb 28, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 28, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 28, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 28, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 28, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 10, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 10, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 7, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 6, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 26, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 25, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 25, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 22, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 22, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 22, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 23, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 18, 2019 ALIE A ASSIGNED TO LIE Loading...
Jan 1, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 1, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 1, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 1, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 1, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 26, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 2, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
First Use Anywhere: Feb 26, 2019
First Use in Commerce: Feb 26, 2019

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"